Cipla and Glenmark Drug Recall in US Over Manufacturing Issues
05 May 2024
Indian pharmaceutical giants Cipla and Glenmark, who are prominent players in the pharmaceutical industry, have reportedly recalled their products from the American market due to manufacturing irregularities in the products, as reported by the US Food and Drug Administration (USFDA). The report highlighted the ongoing challenges in pharmaceutical production and...
Read More